A common hematopoietic precursor to innate lymphoid cells
先天淋巴细胞的常见造血前体
基本信息
- 批准号:9110098
- 负责人:
- 金额:$ 38.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAllergic DiseaseAllergic inflammationAnimalsAutomobile DrivingBacterial InfectionsBone MarrowCandidate Disease GeneCategoriesCell LineageCellsCitrobacter rodentiumClassificationCommunicable DiseasesComparative StudyConfusionDefectDendritic CellsDeveloping CountriesDevelopmentDiseaseEnteralEpithelial CellsFetal LiverGeneticGenetic ModelsHealthHematopoieticHost DefenseHypersensitivityImmuneImmune systemImmunocompetentImmunodeficient MouseIn VitroInfectionInternal Ribosome Entry SiteKnockout MiceKnowledgeLaboratoriesLymphocyteLymphocyte SubsetLymphoidLymphoid CellLymphoid TissueMapsMissionModelingMolecularMolecular ProfilingMusMyelogenousNatural Killer CellsNippostrongylusOrgan Culture TechniquesParasitic infectionPhysiologyPlayPopulationPublic HealthReporterResearchRoleStagingStudy modelsSystemTestingUnited States National Institutes of HealthVirus DiseasesWorkZNF145 geneadaptive immunitycytokinegenetic approachhuman diseasein vivoinhibitor/antagonistinnovationinsightmicrobiotamouse modelnovelnovel strategiespathogenpreventprogenitorresponsetissue repairtooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Innate lymphocytes (ILC) are novel populations of lymphocytes that reside at mucosal barriers and play critical functions in clearing infections, inducing allergic inflammation or directing tissue repair. Different lineages of ILCs are specialized in the secretion of polarized sets of cytokines that orchestrate rapid protective responses against various categories of pathogens. Thus, their study is relevant to a broad range of diseases across western and third-world countries. The development and the lineage relationships between different populations of ILCs, including ILC2s, ILC22s, lymphoid tissue inducers (LTis) and NK cells, are poorly understood and there is considerable confusion regarding the identity and function of these ILCs in the healthy state and in the context of disease. In the absence of genetic models alowing specific manipulation of these lineages in vivo, studies have been largely limited to immunodeficient mice lacking an adaptive immune system and it is unclear whether their conclusions will apply to normal animals. This project builds on preliminary studies of PLZF-IRES-GFPCre reporter mice produced in our laboratory showing that the transcription factor PLZF, previously identified as the signature of the innate-like NKT cell lineage, is also expressed at high levels during the development of ILC2s and ILC22s but not NK or LTi cells. The central hypothesis is that PLZF marks a common bone marrow precursor to ILC2s and ILC22s and is essential for normal development and function. The objective of this application is to use PLZF-IRES-GFPCre mice to identify the bone marrow precursors of ILCs, characterize their molecular signature and genetically manipulate ILCs in vivo in order to define their function in well-established models of enteric infections. The specifc aims are 1) to identify the PLZF-expressing bone marrow precursor of ILC lineages, 2) to characterize its molecular signature; 3) to create ILC-defective mouse models for studies of enteric infections. The proposal is innovative and significant because it identifies a novel bone marrow precursor and a novel transcription factor for ILCs and because it will produce models for studies of ILCs in the context of infections in immunocompetent animals.
描述(由申请方提供):先天性淋巴细胞(ILC)是一种新的淋巴细胞群,位于粘膜屏障,在清除感染、诱导过敏性炎症或指导组织修复中发挥关键作用。ILC的不同谱系专门分泌极化的细胞因子组,其协调针对各种类别的病原体的快速保护性反应。因此,他们的研究与西方和第三世界国家的广泛疾病有关。不同ILC群体(包括ILC 2、ILC 22、淋巴组织诱导物(LT)和NK细胞)之间的发育和谱系关系知之甚少,并且关于这些ILC在健康状态和疾病背景下的身份和功能存在相当大的混淆。在缺乏遗传模型的情况下,允许在体内对这些谱系进行特异性操作,研究主要限于缺乏适应性免疫系统的免疫缺陷小鼠,目前还不清楚他们的结论是否适用于正常动物。该项目建立在我们实验室生产的PLZF-IRES-GFPCre报告小鼠的初步研究的基础上,该研究表明,之前被鉴定为先天样NKT细胞谱系特征的转录因子PLZF在ILC 2和ILC的发育过程中也以高水平表达22 s,但不是NK或LTi细胞。中心假设是PLZF标志着ILC 2和ILC 22的共同骨髓前体,并且对于正常发育和功能至关重要。本申请的目的是使用PLZF-IRES-GFPCre小鼠鉴定ILC的骨髓前体,表征其分子特征并在体内遗传操作ILC,以确定其在良好建立的肠道感染模型中的功能。具体目的是1)鉴定ILC谱系的表达PLZF的骨髓前体,2)表征其分子特征; 3)建立用于肠道感染研究的ILC缺陷型小鼠模型。该提案是创新的和重要的,因为它确定了一种新的骨髓前体和一种新的ILC转录因子,因为它将产生模型的ILC的研究中的感染免疫活性动物的背景下。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALBERT S. BENDELAC其他文献
ALBERT S. BENDELAC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALBERT S. BENDELAC', 18)}}的其他基金
Transcriptional Regulation of Innate-Like T Cells
先天样 T 细胞的转录调控
- 批准号:
10441712 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Development of Intestinal Polyreactive IgA B Cells
肠道多反应性 IgA B 细胞的发育
- 批准号:
10543053 - 财政年份:2019
- 资助金额:
$ 38.39万 - 项目类别:
Development of Intestinal Polyreactive IgA B Cells
肠道多反应性 IgA B 细胞的发育
- 批准号:
10321246 - 财政年份:2019
- 资助金额:
$ 38.39万 - 项目类别:
Development of Intestinal Polyreactive IgA B Cells
肠道多反应性 IgA B 细胞的发育
- 批准号:
10078246 - 财政年份:2019
- 资助金额:
$ 38.39万 - 项目类别:
A common hematopoietic precursor to innate lymphoid cells
先天淋巴细胞的常见造血前体
- 批准号:
9312731 - 财政年份:2014
- 资助金额:
$ 38.39万 - 项目类别:
A common hematopoietic precursor to innate lymphoid cells
先天淋巴细胞的常见造血前体
- 批准号:
8612741 - 财政年份:2014
- 资助金额:
$ 38.39万 - 项目类别:
Allergic inflammation in genetic models of lung ILC2 deficiency
肺 ILC2 缺陷遗传模型中的过敏性炎症
- 批准号:
8576628 - 财政年份:2013
- 资助金额:
$ 38.39万 - 项目类别:
Allergic inflammation in genetic models of lung ILC2 deficiency
肺 ILC2 缺陷遗传模型中的过敏性炎症
- 批准号:
8847790 - 财政年份:2013
- 资助金额:
$ 38.39万 - 项目类别:
Control of lymphoid effector programs by the E3 ligase cullin 3
E3 连接酶 cullin 3 控制淋巴效应程序
- 批准号:
8651505 - 财政年份:2013
- 资助金额:
$ 38.39万 - 项目类别:
相似海外基金
Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease
阐明皮肤环境因素在过敏性疾病发展中的作用
- 批准号:
10664255 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Regulatory mechanism of allergic disease development by inhibitory co-receptors
抑制性共受体对过敏性疾病发生的调控机制
- 批准号:
22H02888 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Deep Phenotyping of Allergic Disease and Environmental Allergen Component Sensitization
过敏性疾病的深层表型分析和环境过敏原成分致敏
- 批准号:
22K10545 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10670058 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Elucidation of immune and allergic disease dynamics by integrative sequencing analysis
通过整合测序分析阐明免疫和过敏性疾病动态
- 批准号:
22H00476 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
- 批准号:
10353468 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
滤泡 T 细胞亚群对过敏性疾病的体液免疫调节
- 批准号:
10570227 - 财政年份:2021
- 资助金额:
$ 38.39万 - 项目类别:
Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
滤泡 T 细胞亚群对过敏性疾病的体液免疫调节
- 批准号:
10373108 - 财政年份:2021
- 资助金额:
$ 38.39万 - 项目类别:














{{item.name}}会员




